GC Biopharma Financial Statements
We are disclosing financial information
To help investors
Make informed decisions.
Unit: KRW million
| 항목 | 2022 | 2021 | 2020 |
|---|---|---|---|
[Current assets] |
980,438 | 1,095,621 | 1,132,044 |
[Fixed assets] |
1,545,099 | 1,366,524 | 1,019,356 |
Total assets |
2,525,537 | 2,462,144 | 2,151,400 |
[Current liabilities] |
540,738 | 552,883 | 589,403 |
[Fixed liabilities] |
418,157 | 409,505 | 292,691 |
Total liabilities |
958,895 | 962,388 | 882,094 |
Total capital |
1,566,642 | 1,499,757 | 1,269,306 |
-
- GC MS
- GC Wellbeing
- GCMedis
-
- Overseas
- GC China Pharm
- Curevo
- GC Pharma do Brasil
-
- Foundation
- MOGAM Institue
- GC Labs
- GC i-Med
-
- Others
- GC Invacfarm